Question number |
Defined question |
---|---|
Q1 | Was true randomization used for assignment of participants to treatment groups? |
Q2 | Was allocation to treatment groups concealed? |
Q3 | Were treatment groups similar at the baseline? |
Q4 | Were participants blind to treatment assignment? |
Q5 | Were those delivering treatment blind to treatment assignment? |
Q6 | Were outcomes assessors blind to treatment assignment? |
Q7 | Were treatment groups treated identically other than the intervention of interest? |
Q8 | Was follow-up complete and if not, were differences between groups in terms of their follow-up adequately described and analyzed? |
Q9 | Were participants analysed in the groups to which they were randomized? |
Q10 | Were outcomes measured in the same way for treatment groups? |
Q11 | Were outcomes measured in a reliable way? |
Q12 | Was appropriate statistical analysis used? |
Q13 | Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? |